miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
复制标题
巨噬细胞中miR-21的缺失促进肿瘤杀伤极化并增强PD-1免疫治疗。
DOI:
10.1038/s41388-018-0178-3
复制
发表时间:
2018-06
期刊:
影响因子:
8
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Xi J;Huang Q;Wang L;Ma X;Deng Q;Kumar M;Zhou Z;Li L;Zeng Z;Young KH;Zhang M;Li Y
MicroRNA-21 (miR-21) is one of the most abundant microRNAs in mammalian cells. It has been intensively studied for its role in regulating apoptosis and oncogenic transformation. However, the impact of miR-21 on host anti-tumor immunity remains unknown. Tumor-associated macrophages are a major leukocyte type that infiltrates tumors and predominantly develops into immunosuppressive, tumor-promoting M2-like macrophages. In contrast, the pro-inflammatory M1−like macrophages have tumoricidal activity. In this study, we show that genetic deficiency of miR-21 promotes the polarization of macrophages toward an M1-like phenotype in vivo and in vitro in the presence of tumor cells; thus it confers host mice with enhanced anti-tumor immunity. By downregulating JAK2 and STAT1, miR-21 inhibits the IFN-γ-induced STAT1 signaling pathway, which is required for macrophage M1 polarization. We also show that the expression of miR-21 in macrophages is regulated upon polarization stimuli as well as upon macrophages co-culturing with tumor cells. Thus, tumor cells may stimulate miR-21 expression in tumor-associated macrophages to prevent tumoricidal M1 polarization. However, augmented STAT1 signaling mediated by miR-21 deficiency upregulates PD-L1 expression in macrophages, which is known to inhibit phagocytic anti-tumor activity. This adverse effect can be alleviated by PD-1 blockade; indeed, miR-21 depletion in macrophages and PD-1 antibody treatment offer superior anti-tumor activity than either agent alone. These studies shed lights on potential application of the combination of miR-21 inhibition and immune checkpoint blockade to target the tumor microenvironment.
登录
查看更多内容
影响因子:
56.9
作者:
Lagos-Quintana, M;Rauhut, R;Tuschl, T
通讯作者:
Tuschl, T
DOI:
10.1158/1078-0432.ccr-12-1281
发表时间:
2013-04-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Jahangiri A;De Lay M;Miller LM;Carbonell WS;Hu YL;Lu K;Tom MW;Paquette J;Tokuyasu TA;Tsao S;Marshall R;Perry A;Bjorgan KM;Chaumeil MM;Ronen SM;Bergers G;Aghi MK
通讯作者:
Aghi MK
影响因子:
4.7
作者:
Ma, Xiaodong;Choudhury, Saibyasachi N.;Li, Yong
通讯作者:
Li, Yong
影响因子:
21.3
作者:
Baer, Caroline;Squadrito, Mario Leonardo;De Palma, Michele
通讯作者:
De Palma, Michele
影响因子:
32.4
作者:
Haverkamp, Jessica M.;Smith, Amber M.;Weinlich, Ricardo;Dillon, Christopher P.;Qualls, Joseph E.;Neale, Geoffrey;Koss, Brian;Kim, Young;Bronte, Vincenzo;Herold, Marco J.;Green, Douglas R.;Opferman, Joseph T.;Murray, Peter J.
通讯作者:
Murray, Peter J.